Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice.
Study Goal
The researchers aimed to characterize the severity of diet-induced steatosis, obesity, and insulin resistance in two mouse strains fed a high-fat and high-carbohydrate (HFHC) diet.
Results Summary
C57BL/6J mice developed severe pan-lobular steatosis and profound peripheral insulin resistance, while DBA/2J mice showed only mild steatosis and moderate peripheral insulin resistance. Both strains developed severe hepatic insulin resistance, suggesting peripheral insulin resistance is a dominant factor in nonalcoholic fatty liver disease.
Population
Male, 8-week-old C57BL/6J and DBA/2J mice.
Effective Dosage
Not specified.
Duration
16 weeks.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
HFHC diet | increase | obesity | C57BL/6J and DBA/2J mice | similar degree | developed obesity to a similar degree | #1 |
HFHC diet | no change | liver inflammation | C57BL/6J and DBA/2J mice | - | without the feature of liver inflammation | #2 |
HFHC diet | increase | hepatic steatosis | C57BL/6J mice | severe | exhibited severe pan-lobular steatosis | #3 |
HFHC diet | increase | hepatic triglyceride levels | C57BL/6J mice | marked increase | a marked increase in hepatic triglyceride levels | #4 |
HFHC diet | increase | peripheral insulin resistance | C57BL/6J mice | profound | profound peripheral IR | #5 |
HFHC diet | increase | hepatic steatosis | DBA/2J mice | mild degree | developed only a mild degree of pericentrilobular hepatic steatosis | #6 |
HFHC diet | increase | peripheral insulin resistance | DBA/2J mice | moderate changes | associated with moderate changes in peripheral IR | #7 |
HFHC diet | increase | hepatic insulin resistance | C57BL/6J and DBA/2J mice | severe | developed severe hepatic IR | #8 |
Liver steatosis in nonalcoholic fatty liver disease is affected by genetics and diet. It is associated with insulin resistance (IR) in hepatic and peripheral tissues. Here, we aimed to characterize the severity of diet-induced steatosis, obesity, and IR in two phylogenetically distant mouse strains, C57BL/6J and DBA/2J. To this end, mice (male, 8 wk old) were fed a high-fat and high-carbohydrate (HFHC) or control diet for 16 wk followed by the application of a combination of classic physiological, biochemical, and pathological studies to determine obesity and hepatic steatosis. Peripheral IR was characterized by measuring blood glucose level, serum insulin level, homeostasis model assessment of IR, glucose intolerance, insulin intolerance, and AKT phosphorylation in adipose tissues, whereas the level of hepatic IR was determined by measuring insulin-triggered hepatic AKT phosphorylation. We discovered that both C57BL/6J and DBA/2J mice developed obesity to a similar degree without the feature of liver inflammation after being fed an HFHC diet for 16 wk. C57BL/6J mice in the HFHC diet group exhibited severe pan-lobular steatosis, a marked increase in hepatic triglyceride levels, and profound peripheral IR. In contrast, DBA/2J mice in the HFHC diet group developed only a mild degree of pericentrilobular hepatic steatosis that was associated with moderate changes in peripheral IR. Interestingly, both C57BL/6J and DBA/2J developed severe hepatic IR after HFHC diet treatment. Collectively, these data suggest that the severity of diet-induced hepatic steatosis is correlated to the level of peripheral IR, not with the severity of obesity and hepatic IR. Peripheral rather than hepatic IR is a dominant factor of pathophysiology in nonalcoholic fatty liver disease.